Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases.

Grosset, Donald G

Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases. [electronic resource] - Journal of rehabilitation medicine Feb 2015 - 183-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1651-2081

10.2340/16501977-1895 doi


Adult
Blepharospasm--drug therapy
Botulinum Toxins, Type A--administration & dosage
Cost Savings
Drug Administration Schedule
Dystonia--drug therapy
Female
Hemifacial Spasm--drug therapy
Humans
Injections, Intramuscular
Male
Neuromuscular Agents--administration & dosage
Torticollis--drug therapy
Treatment Outcome